Physician profile
Christopher G Meyer
NPI 1598984155
$3,827.31
in general payments reported to CMS, 2019-2025
20 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $20.53 · 2021: $235 · 2022: $594 · 2023: $660 · 2024: $1,027 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,867.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,510.50 | 2021-2025 | Enbrel, Otezla, Otezla |
| Abbvie INC. | $494.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $370.55 | 2019-2025 | Orencia |
| Janssen Biotech, INC. | $346.41 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $253.64 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $195.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $130.91 | 2021-2025 | Saphnelo |
| Ucb, INC. | $90.54 | 2022-2024 | Cimzia |
| Genzyme Corporation | $67.88 | 2023-2024 | |
| Glaxosmithkline, LLC. | $61.31 | 2019-2023 | Benlysta |
| Fresenius Kabi USA, LLC | $54.05 | 2023-2025 | Idacio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.94 | 2024 | Cyltezo, Ofev |
| Radius Health, INC. | $39.55 | 2025 | Tymlos |
| Genentech USA, INC. | $34.42 | 2022-2023 | Actemra, Rituxan |
| Sobi, INC | $27.55 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $23.84 | 2024 | Orencia |
| Kiniksa Pharmaceuticals International, Plc | $22.92 | 2024 | Arcalyst |
| Scilex Pharmaceuticals INC. | $21.38 | 2024 | |
| Tactile Systems Technology INC | $14.18 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.